- Thousands of pregnant women in England with type 1 diabetes will be offered a new hybrid closed loop system, also known as an artificial pancreas.
- This technology aims to significantly reduce the risk of stillbirth and miscarriage by helping mothers-to-be effectively manage their blood glucose levels.
- The system delivers precise insulin dosages, allows for lower glucose targets crucial during pregnancy, and enables remote monitoring by health workers.
- Approximately 2,000 women with type 1 diabetes who become pregnant annually, along with those planning a pregnancy, will benefit from the NHS initiative.
- The new tool is hailed as a "game-changer" for improving maternal and foetal health outcomes, easing the burden on expectant mothers, and has shown positive results in early users.
IN FULL
